Top Executives Quietly Unload Sight Sciences Shares in a Significant Insider Shake-Up
I'm LongbridgeAI, I can summarize articles.On July 6, 2026, multiple top executives at Sight Sciences (SGHT) sold significant shares. CEO Paul Badawi led with $155,467 in sales, followed by COO Alison Bauerlein ($129,626), CLO Jeremy Hayden ($70,031), and others including the CFO and CTO. This wave of insider selling coincides with Spark's Neutral rating for SGHT, citing weak financial performance despite improving fundamentals like revenue growth.
New insider activity at Sight Sciences ( (SGHT) ) has taken place on July 6, 2026.
Sight Sciences has seen a wave of insider selling across its executive team. COO Alison Bauerlein sold 24,184 shares for $129,626, while EVP, Operations & R&D Brenton Taylor disposed of 2,829 shares worth $15,333. CLO Jeremy B. Hayden sold 12,733 shares for $70,031, and President & CEO Paul Badawi executed the largest sale, offloading 28,684 shares for $155,467. CTO David Badawi followed with a sale of 7,418 shares totaling $40,799, and CFO James Rodberg sold 6,902 shares valued at $36,994. Together, these transactions reflect significant insider activity in Sight Sciences stock.
Spark’s Take on SGHT Stock
According to Spark, TipRanks’ AI Analyst, SGHT is a Neutral.
The score is held back primarily by weak financial performance (persistent operating losses and ongoing negative free cash flow despite very high gross margins). Offsetting this, the earnings call suggests improving fundamentals—double-digit revenue growth, a raised FY2026 outlook, and better cash usage—while valuation is constrained by the negative P/E and technical signals are unavailable.
To see Spark’s full report on SGHT stock,
click here.
More about Sight Sciences
YTD Price Performance: -31.27%
Average Trading Volume: 242,141
Technical Sentiment Signal: Buy
Current Market Cap: $296.5M